ZENTEK LTD. (ZAY0) - Total Liabilities
Based on the latest financial reports, ZENTEK LTD. (ZAY0) has total liabilities worth €5.04 Million EUR (≈ $5.90 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ZAY0 cash flow conversion to assess how effectively this company generates cash.
ZENTEK LTD. - Total Liabilities Trend (2022–2025)
This chart illustrates how ZENTEK LTD.'s total liabilities have evolved over time, based on quarterly financial data. See shareholders equity of ZENTEK LTD. for net asset value and shareholders' equity analysis.
ZENTEK LTD. Competitors by Total Liabilities
The table below lists competitors of ZENTEK LTD. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Country Group Holdings Public Company Limited
BK:CGH
|
Thailand | ฿2.92 Billion |
|
MINDs Lab Inc.
KQ:377480
|
Korea | ₩30.32 Billion |
|
Artifex Mundi SA
WAR:ART
|
Poland | zł22.53 Million |
|
Jia Wei Lifestyle Inc
TW:3557
|
Taiwan | NT$4.00 Billion |
|
Anabatic Technologies Tbk PT
JK:ATIC
|
Indonesia | Rp4.26 Trillion |
|
G.I. Tech Co. Ltd.
KQ:382480
|
Korea | ₩33.40 Billion |
|
Cape EMS Berhad
KLSE:5311
|
Malaysia | RM311.97 Million |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
USA | $49.69 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down ZENTEK LTD.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of ZENTEK LTD..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ZENTEK LTD.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ZENTEK LTD. (2022–2025)
The table below shows the annual total liabilities of ZENTEK LTD. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €3.65 Million ≈ $4.26 Million |
+51.20% |
| 2024-03-31 | €2.41 Million ≈ $2.82 Million |
-16.97% |
| 2023-03-31 | €2.90 Million ≈ $3.40 Million |
-15.45% |
| 2022-03-31 | €3.44 Million ≈ $4.02 Million |
-- |
About ZENTEK LTD.
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more